Medline (MDLN) COO Miller received 25,788 shares
Insider transactions reported
Stephen L Miller (Chief Operating Officer at Medline Inc., MDLN) reported that they received 25,788 shares between Dec 16, 2025 and Mar 5, 2026. After these transactions the filing shows 25,788 shares held directly.
- Reporting person
- Miller Stephen L
- Role
- Chief Operating Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Grant or award (A) | Class A Common Stock1 | +25,788 | - | - | 25,788 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 16, 2025 | Grant or award (A) | Incentive Units of Medline Holdings, LPOn 1,547,898 Class A Common Stock2, 3, 4, ... | +1,547,898 | - | - | 272,725 indirect |
Holdings before and after
- Class A Common Stock: 0 to 25,788 direct
- Incentive Units of Medline Holdings, LP: 0 to 272,725 indirect, See Footnote
Footnotes from the filing
- 1. Represents a grant of restricted stock units, of which 25% vest on June 15, 2026 and the remaining 75% vest in three equal annual installments beginning on March 1, 2027.
- 2. Reflect incentive units of Medline Holdings, LP ( Incentive Units ), which are profit interests having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of common units of Medline Holdings, LP ( Common Units ) generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of the Issuer's Class A common stock ( Class A Common Stock )) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.
- 3. (Continued from Footnote 2 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of an exchange agreement, dated as of December 16, 2025. These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC.
- 4. These securities were acquired in connection with the reclassification of the interests of Medline Holdings, LP prior to the Issuer's initial public offering (as more fully described in the Registration Statement on Form S-1). These securities were previously reported on the Reporting Person's Form 3 filed on December 17, 2025.
- 5. These securities are held by a trust, of which the Reporting Person is a trustee.
- 6. 60% of these Incentive Units have vested, and the remaining 40% vest in two equal annual installments beginning on July 1, 2026.
- 7. 40% of these Incentive Units have vested, and the remaining 60% vest in three equal annual installments beginning on April 1, 2026.
- 8. 20% of these Incentive Units have vested, and the remaining 80% vest in four equal annual installments beginning on March 29, 2026.
- 9. These Incentive Units vest in five equal annual installments beginning on March 28, 2026.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Miller report in this MDLN Form 4?
Stephen L Miller (Chief Operating Officer at Medline Inc., MDLN) reported that they received 25,788 shares between Dec 16, 2025 and Mar 5, 2026. After these transactions the filing shows 25,788 shares held directly.
How many MDLN shares does Miller hold after this filing?
The filing shows 25,788 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for MDLN
Across the 8 sessions after earlier MDLN headlines, the stock closed higher 4 times and lower 4 times, with a median move of 3.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | MDLN | SPY |
|---|---|---|---|
| Mar 5, 2026 | Medline Inc. announces pricing of secondary offering of class A common stock | +2.7% | -0.6% |
| Mar 3, 2026 | Medline Inc. announces launch of secondary offering of Class A common stock | -3.2% | -0.9% |
| Feb 25, 2026 | Medline Reports Fourth Quarter and Full Year 2025 Results | -3.6% | +0.8% |
| Feb 18, 2026 | Medline announces participation in the Barclays 28th Annual Global Healthcare Conference | +3.4% | +0.5% |
| Feb 5, 2026 | Tigress Financial initiated coverage on Medline with a new price target | +2.7% | -1.2% |
| Jan 28, 2026 | Medline to report fourth quarter and full year 2025 results on February 25, 2026 | -4.3% | -0.0% |
Earlier insider filings at MDLN
- Mar 6, 2026Chief Executive Officer Boyle James M was granted 31,739 shares and was granted 539,189 units of Class B Common Stock (SEC Form 4)
- Mar 6, 2026Chief Product Officer Laabs Amanda H. was granted 251,070 units of Class B Common Stock and was granted 25,788 shares (SEC Form 4)
- Mar 6, 2026Chief Human Resources Officer Shryock Christopher P was granted 11,903 shares (SEC Form 4)
- Mar 6, 2026Chief Financial Officer Drazin Michael B was granted 486,028 units of Class B Common Stock and was granted 25,788 shares (SEC Form 4)
- Mar 6, 2026Chief Legal Officer Liberman Alexander M. was granted 461,100 units of Class B Common Stock and was granted 11,903 shares (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2025
Follow MDLN and get a push notification the moment its next story breaks.